Benjamin Edwards Inc’s GeneDx Holdings WGS Stock Holding History

Benjamin Edwards Inc’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$586K	Buy	8,544 +1,303	+18%	+$74.1K	0.01%	997
2026 Q1	$465K	Buy	7,241 +3,148	+77%	+$287K	﹤0.01%	1026
2025 Q4	$532K	Sell	4,093 -361	-8%	-$49.5K	0.01%	938
2025 Q3	$480K	Buy	+4,454	New	+$485K	0.01%	942

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Benjamin Edwards Inc's WGS Position: Q2 2026 in Review

Benjamin Edwards Inc increased its GeneDx Holdings (WGS) stake by 18% in Q2 2026, buying an estimated $74.1K and bringing the position to 8,544 shares worth $586K. The position accounts for 0.01% of the portfolio, ranked #997.

Benjamin Edwards Inc first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Benjamin Edwards Inc held 8,544 shares of GeneDx Holdings worth $586K as of Q2 2026.
Benjamin Edwards Inc bought 1,303 GeneDx Holdings shares in Q2 2026, an estimated $74.1K.
GeneDx Holdings made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #997 holding.
Benjamin Edwards Inc first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.